Metabolic syndrome in the non-pregnant state is associated with the development of preeclampsia

Geum-Joon Cho, Jong Heon Park, Soon Ae Shin, Min Jeong Oh, Hong Seog Seo

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Background The aim of this study was to investigate the association between metabolic syndrome in the non-pregnant state and the development of preeclampsia. Methods We enrolled 212,463 Korean women who had their first delivery between January, 2011 and December, 2012 and had undergone a national health screening examination through the National Health Insurance during the 1-2 years before their first delivery. Women who had hypertension in the non-pregnant state were excluded. The presence of metabolic syndrome was defined using the modified criteria published in National Cholesterol Education Program Adult Treatment Panel III criteria. Results The prevalence of metabolic syndrome in non-pregnant state was 1.2%. Preeclampsia developed in 3.1% and its prevalence among women with and without metabolic syndrome was 7.3% and 3.0%, respectively. The pre-pregnancy prevalence of metabolic syndrome was higher in women who developed preeclampsia compared to that in those who had a normal pregnancy (1.1% vs. 2.8%; p < 0.001). On multivariate regression analysis, women with metabolic syndrome had an increased risk of developing preeclampsia (odds ratio: 1.48; 95% CI: 1.26 to 1.74) compared to that in those without metabolic syndrome, after adjusting for age, family history of hypertension, smoking status, and pre-pregnancy body mass index. The risk of preeclampsia increased with a rise in the number of components of metabolic syndrome. Conclusion Metabolic syndrome in the non-pregnant state was associated with the development of preeclampsia. Further studies are needed to evaluate whether early intervention for metabolic syndrome before pregnancy can decrease the risk of developing preeclampsia.

Original languageEnglish
Pages (from-to)982-986
Number of pages5
JournalInternational Journal of Cardiology
Volume203
DOIs
Publication statusPublished - 2016 Jan 15

Fingerprint

Pre-Eclampsia
Pregnancy
Hypertension
National Health Programs
Body Mass Index
Multivariate Analysis
Smoking
Odds Ratio
Cholesterol
Regression Analysis
Education
Health

Keywords

  • Hypertension
  • Metabolic syndrome
  • Pre-pregnancy
  • Preeclampsia

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Metabolic syndrome in the non-pregnant state is associated with the development of preeclampsia. / Cho, Geum-Joon; Park, Jong Heon; Shin, Soon Ae; Oh, Min Jeong; Seo, Hong Seog.

In: International Journal of Cardiology, Vol. 203, 15.01.2016, p. 982-986.

Research output: Contribution to journalArticle

@article{ddae6ef0296943bb9b2cd50f045a07ad,
title = "Metabolic syndrome in the non-pregnant state is associated with the development of preeclampsia",
abstract = "Background The aim of this study was to investigate the association between metabolic syndrome in the non-pregnant state and the development of preeclampsia. Methods We enrolled 212,463 Korean women who had their first delivery between January, 2011 and December, 2012 and had undergone a national health screening examination through the National Health Insurance during the 1-2 years before their first delivery. Women who had hypertension in the non-pregnant state were excluded. The presence of metabolic syndrome was defined using the modified criteria published in National Cholesterol Education Program Adult Treatment Panel III criteria. Results The prevalence of metabolic syndrome in non-pregnant state was 1.2{\%}. Preeclampsia developed in 3.1{\%} and its prevalence among women with and without metabolic syndrome was 7.3{\%} and 3.0{\%}, respectively. The pre-pregnancy prevalence of metabolic syndrome was higher in women who developed preeclampsia compared to that in those who had a normal pregnancy (1.1{\%} vs. 2.8{\%}; p < 0.001). On multivariate regression analysis, women with metabolic syndrome had an increased risk of developing preeclampsia (odds ratio: 1.48; 95{\%} CI: 1.26 to 1.74) compared to that in those without metabolic syndrome, after adjusting for age, family history of hypertension, smoking status, and pre-pregnancy body mass index. The risk of preeclampsia increased with a rise in the number of components of metabolic syndrome. Conclusion Metabolic syndrome in the non-pregnant state was associated with the development of preeclampsia. Further studies are needed to evaluate whether early intervention for metabolic syndrome before pregnancy can decrease the risk of developing preeclampsia.",
keywords = "Hypertension, Metabolic syndrome, Pre-pregnancy, Preeclampsia",
author = "Geum-Joon Cho and Park, {Jong Heon} and Shin, {Soon Ae} and Oh, {Min Jeong} and Seo, {Hong Seog}",
year = "2016",
month = "1",
day = "15",
doi = "10.1016/j.ijcard.2015.11.109",
language = "English",
volume = "203",
pages = "982--986",
journal = "International Journal of Cardiology",
issn = "0167-5273",
publisher = "Elsevier Ireland Ltd",

}

TY - JOUR

T1 - Metabolic syndrome in the non-pregnant state is associated with the development of preeclampsia

AU - Cho, Geum-Joon

AU - Park, Jong Heon

AU - Shin, Soon Ae

AU - Oh, Min Jeong

AU - Seo, Hong Seog

PY - 2016/1/15

Y1 - 2016/1/15

N2 - Background The aim of this study was to investigate the association between metabolic syndrome in the non-pregnant state and the development of preeclampsia. Methods We enrolled 212,463 Korean women who had their first delivery between January, 2011 and December, 2012 and had undergone a national health screening examination through the National Health Insurance during the 1-2 years before their first delivery. Women who had hypertension in the non-pregnant state were excluded. The presence of metabolic syndrome was defined using the modified criteria published in National Cholesterol Education Program Adult Treatment Panel III criteria. Results The prevalence of metabolic syndrome in non-pregnant state was 1.2%. Preeclampsia developed in 3.1% and its prevalence among women with and without metabolic syndrome was 7.3% and 3.0%, respectively. The pre-pregnancy prevalence of metabolic syndrome was higher in women who developed preeclampsia compared to that in those who had a normal pregnancy (1.1% vs. 2.8%; p < 0.001). On multivariate regression analysis, women with metabolic syndrome had an increased risk of developing preeclampsia (odds ratio: 1.48; 95% CI: 1.26 to 1.74) compared to that in those without metabolic syndrome, after adjusting for age, family history of hypertension, smoking status, and pre-pregnancy body mass index. The risk of preeclampsia increased with a rise in the number of components of metabolic syndrome. Conclusion Metabolic syndrome in the non-pregnant state was associated with the development of preeclampsia. Further studies are needed to evaluate whether early intervention for metabolic syndrome before pregnancy can decrease the risk of developing preeclampsia.

AB - Background The aim of this study was to investigate the association between metabolic syndrome in the non-pregnant state and the development of preeclampsia. Methods We enrolled 212,463 Korean women who had their first delivery between January, 2011 and December, 2012 and had undergone a national health screening examination through the National Health Insurance during the 1-2 years before their first delivery. Women who had hypertension in the non-pregnant state were excluded. The presence of metabolic syndrome was defined using the modified criteria published in National Cholesterol Education Program Adult Treatment Panel III criteria. Results The prevalence of metabolic syndrome in non-pregnant state was 1.2%. Preeclampsia developed in 3.1% and its prevalence among women with and without metabolic syndrome was 7.3% and 3.0%, respectively. The pre-pregnancy prevalence of metabolic syndrome was higher in women who developed preeclampsia compared to that in those who had a normal pregnancy (1.1% vs. 2.8%; p < 0.001). On multivariate regression analysis, women with metabolic syndrome had an increased risk of developing preeclampsia (odds ratio: 1.48; 95% CI: 1.26 to 1.74) compared to that in those without metabolic syndrome, after adjusting for age, family history of hypertension, smoking status, and pre-pregnancy body mass index. The risk of preeclampsia increased with a rise in the number of components of metabolic syndrome. Conclusion Metabolic syndrome in the non-pregnant state was associated with the development of preeclampsia. Further studies are needed to evaluate whether early intervention for metabolic syndrome before pregnancy can decrease the risk of developing preeclampsia.

KW - Hypertension

KW - Metabolic syndrome

KW - Pre-pregnancy

KW - Preeclampsia

UR - http://www.scopus.com/inward/record.url?scp=84952802562&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84952802562&partnerID=8YFLogxK

U2 - 10.1016/j.ijcard.2015.11.109

DO - 10.1016/j.ijcard.2015.11.109

M3 - Article

C2 - 26625326

AN - SCOPUS:84952802562

VL - 203

SP - 982

EP - 986

JO - International Journal of Cardiology

JF - International Journal of Cardiology

SN - 0167-5273

ER -